In DCIS.com cells, compared to untreated cells, CCL2 treatment altered expression of LDHA, HGF treatment altered expression of HK2, while CCL2 and HGF co-treatment altered GLUT1 and HK2 expression (Supplemental Figure S3a). Here, CCL2 is linked to ductal breast carcinoma in situ.